NCT02166606已完成不适用
INGEVITY™ Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (MRI) Usage With a New Lead for Bradycardia Pacing
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,184
- 试验地点
- 60
- 主要终点
- Percentage of Leads Free From Complication
研究概览
简要总结
The objectives of this registry are to
- Collect clinical data on Boston Scientific's ImageReady MR Conditional Pacing Systems involving the INGEVITY lead based on observations / events
- Gather data on actual number of MRI scans performed in the patient cohort implanted with an ImageReady system including information about scanned body parts.
- Collect physician feedback on lead handling with the INGEVITY lead
in a real-life, market-released standard of care environment using devices on intended purpose and which are authorized to bear the CE (Communauté Européenne) marking / are approved for use in the applicable area of participating centers. No additional invasive or other burdensome examinations are to be carried out other than the ones conducted by the centers per their general standard of care.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is willing and capable of providing informed consent and to give approval to collect / store / process personal health information by the sponsor
- •Subject is scheduled for, or implanted with, a clinically indicated BSC ImageReady system according to current and locally applicable implant guidelines such as published by European Society of Cardiology (ESC) / American Heart Association (AHA) / American College of Cardiology (ACC) / Hearth Rhythm Society (HRS)
- •Subject is geographically stable to be available for follow up at an approved registry center during the whole registry duration
- •Subject is age 18 or above, or of legal age to give informed consent specific to state and national law
排除标准
- •Existing contraindications for a BSC ImageReady system as mentioned in the applicable reference guides of the implanted system components including a known or suspected sensitivity to dexamethasone acetate (DXA)
- •Implanted pacing system is not ImageReady, i.e. any system components other than BSC INGEVITY MRI Conditional leads (or their market released successors), BSC INGENIO MRI family pacemaker models and their accessories (or their market released successors) intended to have MR Conditional status, including pre-existing abandoned leads of any kind still implanted and which will not be removed during the implant or re-implant procedure or plugged lead ports
- •Any existing conditions per local standard of care preventing the subject from undergoing an MRI procedure including implanted active or inactive medical devices / material, not considered MR Conditional
- •Subject is enrolled in any other concurrent study with the exception of local mandatory governmental registries and studies/registries that are not in conflict and do not affect the following:
- •GENTLE registry outcome (i.e. involve different implantable system components than required for participation in GENTLE or would affect ability to undergo MRI procedures);
- •Conduct of the GENTLE Registry per Good Clinical Practice (GCP)/ ISO (International Organization of Harmonization) 14155:2011/ local regulations as applicable
- •Subject is a woman of childbearing potential who is, or might be, pregnant at the time of registry enrollment or plans to become pregnant during the course of the registry (based on physician's assessment)
- •Estimated life expectancy of less than twelve months per physician discretion
结局指标
主要结局
Percentage of Leads Free From Complication
时间窗: 91 calendar days post-implant
Lead-related complication-free rate from lead implant through the three month follow-up, based on complications that are related to the INGEVITY Lead.
次要结局
未报告次要终点
研究者
研究点 (60)
Loading locations...
相似试验
Unknown
不适用
A Clinical Registry to Track the Real World Use of the Saber-C® Cervical Fusion DeviceCervical Disc DiseaseNCT06240221Research Source200
已完成
不适用
Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)Hepatocellular CarcinomaNCT04069468Boston Scientific Corporation1,247
招募中
不适用
Ion Therapy Patient RegistryIon Beam Radiation Therapy for Tumor PatientsNCT03049072EBG MedAustron GmbH2,800
已完成
不适用
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanProstatic NeoplasmsNCT04034095Janssen Pharmaceutical K.K.979
已完成
不适用
Rotation Medical Bioinductive Implant Database RegistryRotator Cuff TearNCT02784600Smith & Nephew, Inc.483